The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response and outcomes to immune checkpoint inhibitors (ICI) in advanced urothelial cancer (aUC) based on prior intravesical BCG.
 
Rafee Talukder
No Relationships to Disclose
 
Dimitrios Makrakis
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte; Janssen Oncology; Nektar
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; BMS; Merck; Pfizer
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Harpoon Therapeutics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck
 
Tyler F. Stewart
Consulting or Advisory Role - Seattle Genetics/Astellas
 
Victor Sacristan Santos
No Relationships to Disclose
 
Jayanshu Jain
No Relationships to Disclose
 
Rafael Morales-Barrera
Consulting or Advisory Role - AstraZeneca; MSD; Sanofi
Speakers' Bureau - Asofarma; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Johnson & Johnson; Lilly; MSD; Pfizer; Roche/Genentech; Sanofi
 
Michael Grant
Employment - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics
Honoraria - Merck Sharp & Dohme
 
Ariel Ann Nelson
No Relationships to Disclose
 
Evan Shreck
No Relationships to Disclose
 
Alexander Sankin
No Relationships to Disclose
 
Roubini Zakopoulou
No Relationships to Disclose
 
Alejo Rodriguez-Vida
Honoraria - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Oncology; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; MSD; Pfizer; Roche
Research Funding - MSD; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Novartis; Pfizer; Roche
 
Sandy Liu
Honoraria - Exelixis
Consulting or Advisory Role - Exelis; Seagen
Speakers' Bureau - EMD Serono; Exelis; Merck; Seagen
 
Ana Fröbe
No Relationships to Disclose
 
Giuseppe Di Lorenzo
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Dyania Health; EMD Serono; Exelixis; Foundation Medicine; Genentech; Genzyme; GlaxoSmithKline; Immunomedics; Infinity Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Kure It Cancer Research (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst)
 
Ali Raza Khaki
Stock and Other Ownership Interests - Merck; Sanofi